{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:14:55Z","timestamp":1790712895405,"version":"4.1.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>Continuous-flow left ventricular assist devices (CF-LVADs) are increasingly used for the management of advanced heart failure refractory to optimal medical therapy. Despite the encouraging outcomes with CF-LVADs, gastrointestinal bleeding (GIB) continues to be a rather concerning complication resulting in increased rates of readmission and increased morbidity. The exact pathophysiology of CF-LVAD-associated GIB remains poorly understood, and this lack of knowledge limits our ability to control this morbid complication. What is clear, however, is that the majority of GIB episodes in LVAD patients are due to fragile GI arteriovenous malformations or angiodysplasias, in the setting of CF-LVAD-associated acquired von Willebrand syndrome. We will, herein, appraise the proposed interactions between different pathophysiological processes thought to be causing angiodysplasias and GIB in patients on CF-LVAD support.<\/jats:p>","DOI":"10.1097\/crd.0000000000000212","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T02:31:43Z","timestamp":1525919503000},"page":"8-13","source":"Crossref","is-referenced-by-count":38,"title":["Gastrointestinal Bleeding During Continuous-Flow Left Ventricular Assist Device Support"],"prefix":"10.1097","volume":"27","author":[{"given":"Rachna","family":"Kataria","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Yale New Haven Health\/Bridgeport Hospital, Bridgeport, CT 06610"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich P.","family":"Jorde","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230903","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart Disease and Stroke Statistics-2017 Update: a report from the American Heart Association.","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"R2-20230903","first-page":"475","article-title":"Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention.","volume":"3","author":"Harvey","year":"2014","journal-title":"Ann Cardiothorac Surg"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.healun.2009.02.015","article-title":"INTERMACS profiles of advanced heart failure: the current picture.","volume":"28","author":"Stevenson","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCHEARTFAILURE.111.962613","article-title":"Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices.","volume":"4","author":"Suarez","year":"2011","journal-title":"Circ Heart Fail"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"E1321","DOI":"10.21037\/jtd.2016.10.81","article-title":"Bleeding in continuous flow left ventricular assist device recipients: an acquired vasculopathy?","volume":"8","author":"Patel","year":"2016","journal-title":"J Thorac Dis"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device.","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.healun.2017.07.005","article-title":"Eighth annual INTERMACS report: Special focus on framing the impact of adverse events.","volume":"36","author":"Kirklin","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1610426","article-title":"A fully magnetically levitated circulatory pump for advanced heart failure.","volume":"376","author":"Mehra","year":"2017","journal-title":"N Engl J Med"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJMoa1800866","article-title":"Two-year outcomes with a magnetically levitated cardiac pump in heart failure.","volume":"378","author":"Mehra","year":"2018","journal-title":"N Engl J Med"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1540-8191.2010.01025.x","article-title":"Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.","volume":"25","author":"Stern","year":"2010","journal-title":"J Card Surg"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.athoracsur.2011.06.081","article-title":"Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices.","volume":"92","author":"John","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R12-20230903","first-page":"849","article-title":"Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device.","volume":"30","author":"Demirozu","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.gie.2011.12.014","article-title":"Evaluation of GI bleeding after implantation of left ventricular assist device.","volume":"75","author":"Kushnir","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.athoracsur.2012.02.035","article-title":"Incidence and management of gastrointestinal bleeding with continuous flow assist devices.","volume":"93","author":"Aggarwal","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"R15-20230903","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.healun.2012.02.015","article-title":"Gastrointestinal bleeding with the HeartMate II left ventricular assist device.","volume":"31","author":"Morgan","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R16-20230903","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCHEARTFAILURE.112.000206","article-title":"Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II.","volume":"6","author":"Wever-Pinzon","year":"2013","journal-title":"Circ Heart Fail"},{"key":"R17-20230903","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jtcvs.2008.07.032","article-title":"Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices.","volume":"137","author":"Crow","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R18-20230903","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacc.2010.05.016","article-title":"Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.","volume":"56","author":"Uriel","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R19-20230903","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.3748\/wjg.v23.i22.3945","article-title":"Bleeding with the artificial heart: gastrointestinal hemorrhage in CF-LVAD patients.","volume":"23","author":"Gurvits","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"4 pt 1","key":"R20-20230903","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0016-5085(77)80149-2","article-title":"On the nature and etiology of vascular ectasias of the colon. Degenerative lesions of aging.","volume":"72","author":"Boley","year":"1977","journal-title":"Gastroenterology"},{"key":"R21-20230903","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/apt.12527","article-title":"Review article: gastrointestinal angiodysplasia - pathogenesis, diagnosis and management.","volume":"39","author":"Sami","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R22-20230903","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.healun.2011.01.011","article-title":"4 national trends in readmission (REA) rates following left ventricular assist device (LVAD) therapy.","volume":"30","author":"Bonde","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R23-20230903","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.athoracsur.2015.03.010","article-title":"Hospital readmissions after continuous-flow left ventricular assist device implantation: incidence, causes, and cost analysis.","volume":"100","author":"Akhter","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"R24-20230903","doi-asserted-by":"crossref","first-page":"419","DOI":"10.14503\/THIJ-14-4971","article-title":"Present-day hospital readmissions after left ventricular assist device implantation: a large single-center study.","volume":"42","author":"Hernandez","year":"2015","journal-title":"Tex Heart Inst J"},{"key":"R25-20230903","first-page":"S86","article-title":"Etiology and timing of readmissions after LVAD implantation.","volume":"20","author":"Bailey","year":"2014","journal-title":"J Card Fail"},{"key":"R26-20230903","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/ctr.12725","article-title":"Cost comparison of heart transplant vs. left ventricular assist device therapy at one year.","volume":"30","author":"Marasco","year":"2016","journal-title":"Clin Transplant"},{"key":"R27-20230903","doi-asserted-by":"crossref","first-page":"A962","DOI":"10.1016\/S0735-1097(18)31503-1","article-title":"Hospitalizations for major bleeding and outcomes in patients with ventricular assist devices.","volume":"71","author":"Yandrapalli","year":"2018","journal-title":"JACC"},{"key":"R28-20230903","doi-asserted-by":"crossref","first-page":"24","DOI":"10.14797\/mdcj-11-1-24","article-title":"Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and management.","volume":"11","author":"Guha","year":"2015","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"R29-20230903","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/jth.13120","article-title":"Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis.","volume":"13","author":"Susen","year":"2015","journal-title":"J Thromb Haemost"},{"key":"R30-20230903","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejcts.2007.12.047","article-title":"Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.","volume":"33","author":"Geisen","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"R31-20230903","first-page":"701","article-title":"Heyde\u2019s syndrome: a review.","volume":"13","author":"Pate","year":"2004","journal-title":"J Heart Valve Dis"},{"key":"R32-20230903","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.jacc.2009.02.048","article-title":"Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).","volume":"53","author":"Klovaite","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R33-20230903","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.healun.2016.05.019","article-title":"Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure.","volume":"35","author":"Netuka","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R34-20230903","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.healun.2003.10.018","article-title":"Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device.","volume":"24","author":"Letsou","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R35-20230903","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MAT.0000000000000624","article-title":"Cessation of continuous flow left ventricular assist device-related gastrointestinal bleeding after heart transplantation.","volume":"64","author":"Patel","year":"2018","journal-title":"ASAIO J"},{"key":"R36-20230903","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jtcvs.2015.09.015","article-title":"Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.","volume":"151","author":"Grosman-Rimon","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R37-20230903","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.115.019692","article-title":"Elevated angiopoietin-2 level in patients with continuous-flow left ventricular assist devices leads to altered angiogenesis and is associated with higher nonsurgical bleeding.","volume":"134","author":"Tabit","year":"2016","journal-title":"Circulation"},{"key":"R38-20230903","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/CIRCRESAHA.117.310848","article-title":"Continuous-flow LVAD support causes a distinct form of intestinal angiodysplasia.","volume":"121","author":"Kang","year":"2017","journal-title":"Circ Res"},{"key":"R39-20230903","doi-asserted-by":"crossref","first-page":"E437","DOI":"10.21037\/jtd.2017.03.09","article-title":"Stop the LVAD bleeding.","volume":"9","author":"Koliopoulou","year":"2017","journal-title":"J Thorac Dis"},{"key":"R40-20230903","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.21037\/jtd.2016.11.04","article-title":"Angiopoietin-2: marker or mediator of angiogenesis in continuous-flow left ventricular assist device patients?","volume":"8","author":"Truby","year":"2016","journal-title":"J Thorac Dis"},{"key":"R41-20230903","doi-asserted-by":"crossref","first-page":"e2013060","DOI":"10.4084\/mjhid.2013.060","article-title":"Von Willebrand factor, angiodysplasia and angiogenesis.","volume":"5","author":"Randi","year":"2013","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R42-20230903","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jth.13551","article-title":"Von Willebrand factor and angiogenesis: basic and applied issues.","volume":"15","author":"Randi","year":"2017","journal-title":"J Thromb Haemost"},{"key":"R43-20230903","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MBC.0000000000000635","article-title":"Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients.","volume":"28","author":"Selvam","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R44-20230903","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/HCO.0000000000000283","article-title":"Creating adequate pulsatility with a continuous flow left ventricular assist device: just do it!","volume":"31","author":"Patel","year":"2016","journal-title":"Curr Opin Cardiol"},{"key":"R45-20230903","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jchf.2016.08.005","article-title":"Association of nasal mucosal vascular alterations, gastrointestinal arteriovenous malformations, and bleeding in patients with continuous-flow left ventricular assist devices.","volume":"4","author":"Patel","year":"2016","journal-title":"JACC Heart Fail"},{"key":"R46-20230903","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.","volume":"32","author":"Feldman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R47-20230903","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/phar.2016","article-title":"Pharmacotherapeutic management of gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices.","volume":"37","author":"Sieg","year":"2017","journal-title":"Pharmacotherapy"},{"key":"R48-20230903","doi-asserted-by":"crossref","DOI":"10.1097\/MAT.0000000000000758","article-title":"Gastrointestinal bleeding in left ventricular assist device: octreotide and other treatment modalities.","author":"Molina","year":"2018","journal-title":"ASAIO J"},{"key":"R49-20230903","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MAT.0000000000000143","article-title":"Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices.","volume":"61","author":"Loyaga-Rendon","year":"2015","journal-title":"ASAIO J"},{"key":"R50-20230903","doi-asserted-by":"crossref","first-page":"e004500","DOI":"10.1161\/CIRCHEARTFAILURE.117.004500","article-title":"Multicenter evaluation of octreotide as secondary prophylaxis in patients with left ventricular assist devices and gastrointestinal bleeding.","volume":"10","author":"Shah","year":"2017","journal-title":"Circ Heart Fail"},{"key":"R51-20230903","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1537-2995.2011.03500.x","article-title":"Factor VIII\/von Willebrand factor concentrate therapy for ventricular assist device-associated acquired von Willebrand disease.","volume":"52","author":"Cushing","year":"2012","journal-title":"Transfusion"},{"key":"R52-20230903","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/trf.12788","article-title":"Von Willebrand factor, a versatile player in gastrointestinal bleeding in left ventricular assist device recipients?","volume":"55","author":"Fischer","year":"2015","journal-title":"Transfusion"},{"key":"R53-20230903","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/MAT.0000000000000433","article-title":"Inhaled desmopressin for refractory gastrointestinal bleeding in a patient with a HeartMate II left ventricular assist device.","volume":"63","author":"Hollis","year":"2017","journal-title":"ASAIO J"},{"key":"R54-20230903","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.healun.2014.09.013","article-title":"Thalidomide for treatment of gastrointestinal angiodysplasia in patients with left ventricular assist devices: case series and treatment protocol.","volume":"34","author":"Draper","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"R55-20230903","doi-asserted-by":"crossref","first-page":"636","DOI":"10.5301\/ijao.5000620","article-title":"Novel use of low-dose thalidomide in refractory gastrointestinal bleeding in left ventricular assist device patients.","volume":"40","author":"Seng","year":"2017","journal-title":"Int J Artif Organs"},{"key":"R56-20230903","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1053\/j.jvca.2013.05.019","article-title":"Treatment of ventricular assist-device-associated gastrointestinal bleeding with hormonal therapy.","volume":"27","author":"Gutsche","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R57-20230903","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.healun.2016.01.229","article-title":"Danazol for the treatment of gastrointestinal bleeding in left ventricular assist device (LVAD) patients: a multicenter experience.","volume":"35","author":"Schettle","year":"2016","journal-title":"J Heart Lung Transplant"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00045415-201901000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T09:23:16Z","timestamp":1693732996000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-201901000-00002"}},"subtitle":["State of the Field"],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000212","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}